Our study is the first to report that a loss of function of NUSAP1 can facilitate tau aggregation and that the protein is down-regulated in AD brain samples, potentially leading to nucleolar dysfunction and thereby enhancing tauopathy. This evidence concerns the gene MAPT and Alzheimer disease.